文献速递肺外科

加速康复路径与标准护理在电视辅助胸腔镜肺叶切除术患者中的比较

Enhanced recovery pathway versus standard care in patients undergoing video-assisted thoracoscopic lobectomy.
PubMed 文献 · J Thorac Cardiovasc Surg · 2017-06-22

该研究比较了电视辅助胸腔镜肺叶或肺段切除术前后的加速康复路径与标准护理效果。结论认为加速康复路径未带来可检测的获益。

核心结论

  • 加速康复路径对心肺并发症、30天和90天死亡率、住院时间及再入院率未显示获益。
  • 加速康复路径要素可能与既往围手术期标准差异不足,未能检测到获益。

研究设计与样本

  • 回顾性比较分析,纳入2014年4月至2017年1月间600例接受电视辅助胸腔镜肺叶或肺段切除术的患者。
  • 比较加速康复路径开始前(365例)与开始后(235例)的患者结局。

临床怎么用

  • 在当前设置下,加速康复路径未显著改善胸腔镜肺叶切除术后的关键结局,需重新评估其组成要素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this study was to compare outcomes after video-assisted thoracoscopic lobectomy or segmentectomy before and after introduction of an enhanced recovery program. METHODS: Data from 600 patients undergoing video-assisted lobectomy or segmentectomy between April 2014 and January 2017 were analyzed. A comparative analysis was performed between patients undergoing operation before (365 patients) and after (235 patients) the start of the enhanced recovery program. The incidence of cardiopulmonary complications and 30-day and 90-day mortality, postoperative length of stay, and 30-day and 90-day hospital readmission rates were evaluated. Risk-adjusted cardiopulmonary morbidity and 30-day mortality were calculated for each group and compared. RESULTS: The 2 groups had a similar postoperative length of stay (enhanced recovery pathway median 5 days vs pre-enhanced recovery pathway 4, P = .44), cardiopulmonary complication rates (enhanced recovery pathway 22.6% vs pre-enhanced recovery pathway 22.4%, P = .98), 30-day mortality rates (enhanced recovery pathway 3.8% vs pre-enhanced recovery pathway 2.2%, P = .31), and 90-day mortality rates (enhanced recovery pathway 4.7% vs pre-enhanced recovery pathway 3.0%, P = .37). No differences were noted in terms of 30-day (enhanced recovery pathway 7.2% vs pre-enhanced recovery pathway 7.4%, P = .94) or 90-day readmission rates (enhanced recovery pathway 9.8% vs pre-enhanced recovery pathway 12.3%, P = .34). The risk-adjusted cardiopulmonary morbidity rates were similar in the 2 periods (P = .76), whereas the risk-adjusted 30-day mortality was higher in the enhanced recovery pathway period compared with the pre-enhanced recovery pathway mortality (P = .0004). CONCLUSIONS: We found no benefit conferred by the enhanced recovery program on outcomes such as cardiopulmonary complications, 30- and 90-day mortality, length of stay, and readmissions. Enhanced recovery program elements may be insufficiently different than previous standards of perioperative care to confer detectable benefits in our settings.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Brunelli A, Thomas C, Dinesh P, et al. Enhanced recovery pathway versus standard care in patients undergoing video-assisted thoracoscopic lobectomy. J Thorac Cardiovasc Surg. 2017. PMID: 28728783. doi:10.1016/j.jtcvs.2017.06.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。